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Piliostigma thonningii Schum. (Caesalpiniacea) is used traditionally in the management of fever, cough, 
wounds and various ulceration. Oral acute toxicity of the ethanolic leaf extract of Piliostigma thorningii 
was evaluated in mice using modified Lorke’s method. The ethanolic leaf extract was evaluated for in 
vivo anti plasmodial activity against chloroquine sensitive strain of Plasmodium berghei berghei NK65 
in mice. Four day suppressive, curative effect against established infection and prophylactic models of 
anti plasmodial studies were carried out. The oral median lethal dose was determined to be 3807.89 
mg/kg body weight. The extract (100,200 and 400 mg/kg) exerted dose dependent chemo suppressive 
effects at the different levels of the infections tested. However the anti-plasmodial effect of chloroquine 
at 5 mg/kg body weight was higher than the extract in all the test models. This shows that the plant has 
anti plasmodial property that can be explored for the management of malaria.  
 





Malaria is an endemic infectious disease that is wide 
spread in tropical and subtropical regions of the world 
and one of the six most important parasitic disease of 
man (WHO, 1998). It is a major public health problem in 
sub-Saharan Africa, where over 85 - 90% of all global 
burden of malaria exists with up to 50% of all out patient 
visits in areas with high malaria transmission and 30 - 
50% of all hospital admissions are attributed to malaria 
(WHO, 2005). The disease kills 1.1 million people world 
wide each year. Approximately 1 million of these deaths 
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children. These malaria deaths account for one out of 
every four childhood deaths in Africa (UNICEF, 2000). 
Although an effective vaccine is the best long term 
control option for malaria, current research on vaccine 
development is still at preclinical stage and considering 
the different phases of vaccine development it is 
predicted that a reliable malaria vaccine is several years 
away. The global strategy for malaria mainly focuses on 
case management through provision of drugs capable of 
reducing the morbidity and mortality of malaria through 
provision of drugs capable of reducing or eliminating 
parasites (WHO, 1993; Schapira, 1994). 
However, multiple anti-malarial drug resistant Plasmodium 
falciparum and the emergence of insecticide resistant 
Anopheles mosquitoes is causing not only the spread of 








where it had previously been eradicated (Collins and 
Jeffery, 1996). This has prompted research towards the 
discovery and development of new, safe and affordable 
anti-malarial chemotherapies.  
In this respect, plant resources are potential targets for 
research and development of alternative malarial drugs, 
with novel modes of action (Muregi et al., 2003). Although 
up to 80% of the African population uses traditional 
medicine especially plant remedies for the management 
of diseases including malaria, plants are not yet fully 
explored (WHO, 2002b).  
Piliostigma thonningii belongs to the family caesal-
piniaceous and it is a shrubby tree with alternate 
compound leaves. The fruits are often pod-like with pods 
containing one to many seeds. The tree is perennial in 
nature and its petals are white to pinkish colour produced 
between November and April. While the fruits, which is a 
hairy, hard, flattish pod turns rusty brown, woody and 
twisted which splits at ripening and usually persistent on 
the tree are produced between June and September 
(Lock and Simpson, 1999). Locally, the seed is called 
Abafe in the Yoruba land (Nigeria). Other names include 
Monkey bread, Camel’s foot, Kalgo (Hausa) and Okpoatu 
(Ibo). P. thonningii grows in open woodland and 
savannah regions that are moist and wooded grassland 
in low to medium altitudes. It is widely distributed in Africa 
and Asia.  
It is found growing abundantly as a wild uncultivated 
tree in many parts of Nigeria such as Zaria, Bauchi, Ilorin, 
Plateau, Lagos and Abeokuta (Schultes and Hofmann, 
1973; Djuma, 2003). In Nigeria it is represented by two 
species that are much alike – P. thonningii and P. 
reticulatum (Keay et al., 1964). A warm infusion of the 
bark and leaves traditionally is used to relieve fever and 
toothache. The powdered bark or the young inner bark 
and the scurf scraped from the surface of the pods are 
applied as dressing for wounds. The bark is also chewed 
for the relief of cough. The leaves and bark are believed 
to have expectorant property and are used in infusions or 
chewed for chest complaints, intestinal troubles, 
diarrhoea and dysentery (Dalziel, 1937).  
This study was aimed at evaluating the anti - plasmodial 
activity of ethanolic leaf extract of P. thonningii on 
Plasmodium berghei berghei infection in mice.  
 
 
MATERIALS AND METHODS 
 
Collection and identification of plant material  
 
Fresh leaves of P. thonningii were collected from Suleja, Niger 
State Nigeria. It was identified by Mal. Ibrahim Muazzam of the 
Medicinal Plant Research and Traditional Medicine (MPR and TM) 
Department, NIPRD Idu, Abuja. A sample with voucher number 





department’s (MPR and TM) herbarium. 
 
 
Extraction of plant material  
 
The leaves were air dried under shade. The dry leaves were ground 
to coarse powder in a mortar. Extraction was carried out by 
dispersing 500 g of the ground plant material in 2.5 L of 70% 
ethanol and shaking was done with GFL shaker (No 3017 MBH, 
Germany) for 72 h. This was followed with vacuum filtration and 
extract concentration using a rotary evaporator at a temperature not 
exceeding 40°C. The concentrate was heated over a water bath to 






4 weeks old albino mice weighing 18-22 g obtained from the Animal 
Facility Centre of NIPRD Abuja were used for the study. They were 
housed in plastic cages with saw dust as beddings and given food 
and water ad libitum. The mice were used in accordance with NIH 
Guide for the care and use of laboratory animals; NIH Publication 






The extract was screened for the presence of secondary metabolites 
and constituents using conventional protocols for detecting the 




Acute toxicity test  
  
Acute toxicity of P. thonningii  ethanolic leaf extract was carried out 
using using  modified Lorke’ s method (1983).The study was carried 
out in two  phases . In phase one of the study nine mice were 
randomized into three groups of three mice each and were given 
10,100 and 1,000 mg/kg body weight of the extract orally. The mice 
were observed for signs of toxicity which include but not limited to 
paw licking, salivation, stretching of the entire body, weakness, 
sleep, respiratory distress, coma and death in the first four hours 
and subsequently daily for 7 days. In the second phase of the study 
another fresh set of nine mice were randomized into three groups of 
three mice each and were given 1600,2900 and 5000 mg /kg body 
weight  of  the extract orally based on the result of the first phase. 
These were observed for signs of toxicity and mortality for the first 
critical four hours and thereafter daily for 7 days. The oral median 
lethal dose was calculated using the formula: 
 
LD50=  minimum toxic dose × maximum tolerated dose. 
 
 
Rodent parasite (Plasmodium berghei berghei) 
 
The rodent parasite Plasmodium berghei berghei NK 65 was 
sourced from National Institute for Medical Research (NIMR), 
Lagos, Nigeria and kept at Animal Facility Centre, NIPRD Idu, 








Table 1.  Phytochemical composition of ethanolic leaf 
extracts of P. thonningii . 
 
Phytochemicals Availability 
Carbohydrates  Present 
Free reducing sugars Present 
Tanins  Present 
Flavonoids Present 
Phenols  Present 
Saponins  Present 
Alkaloids  Present 
Balsams  Present 
Terpenes  Present 
Steroids  Present 
Volatile oils Present 
Resins  Absent 




peritoneal passage in mice (Adzu et al., 2007) every four days. The 
re-infected mice were used for the study. Prior to the beginning of 
the study, one of the infected mice was kept and observed to 






The Peter’s 4-day suppressive test against chloroquine sensitive P. 
berghei berghei  NK 65 infection in mice was employed (Peters, 
1965). Adult Swiss albino mice weighing 18 – 22 g were inoculated 
by intraperitoneal (I.p) injection with standard inoculum of P. 
berghei berghei with 1 x 107 infected erythrocytes. The mice were 
randomly divided into 5 groups of 6 mice per group and treated for 
4 consecutive days with 100, 200 and 400 mg extract/kg body 
weight orally daily respectively. Two control groups were used; the 
positive control was treated daily with 5 mg chloroquine/kg while the 
negative control group was given 5 ml/kg normal saline. On day 5 
of the experiment, blood was collected from the tail of each mouse 
and smear on to a microscope slide to make a film (Saidu et al., 
2000). The blood films were fixed with methanol, stained with10% 
Giemsa at pH 7.2 for 10 min and parasitaemia (WHO, 1994) 
examined microscopically. The percentage suppression of 
parasitaemia was calculated for each dose level by comparing the 
parasitaemia in infected controls with those of treated mice. 
 
 
Evaluation of schizontocidal activity of P. thonningii on 
established infection (Curative or Rane test)  
 
Evaluation of the curative potential of P. thonningii leaf extract was 
carried out according to the method described by Ryley and Peters 
(1970). The mice were injected intraperitoneally with standard 
inoculum of 1 x 107 P. berghei berghei NK 65 infected erythrocytes 
on the first day (day 0). Seventy two hours later, the mice were 
divided into five groups of five mice each. The groups were orally 
treated  with P.  thonningii extract  (100,  200  and  400 mg/kg/day), 




chloroquine (5 mg/kg/day) was given to the positive control and an 
equal volume of distilled water was given to the negative control 
group. The treatment was carried out once daily for 5 days and 
blood smears were collected and examined micro-scopically to 
monitor the parasitaemia level. The mean survival time for each 
group was determined arithmetically by finding the average survival 
time (days) of the mice (post inoculation) in each group over a 
period of 28 days (0 - 27). 
 
 
Evaluation of prophylactic activity of P. thonningii (Repository 
test) 
 
Evaluation of the prophylactic potential P. thonningii leaf extract 
was carried out according to the method of Peters (1965). 
Treatments were initiated on D0 and continued till D4 when the 
mice were all infected with the parasite. Blood smears were then 
made from each mouse 72 h after treatment (Abatan and Makinde, 
1986) and increase or decrease in parasitaemia determined. 
 
 
Statistical analysis  
 
The one way ANOVA test was used to analyse and compare the 
results at a 95% confidence level. Values of p < 0.05 were 
considered significant. Results were expressed as mean ± standard 







Results obtained from the phytochemical screening of the 
ethanolic  leaf extract of P. thonningii showed the 
presence of carbohydrates, free reducing sugars, tanins, 
flavonoids,  phenols, saponins, alkaloids, balsams, terpenes, 
steroids and volatile oils while resins and glycosides were 
absent as shown in Table 1.  
 
 
Acute toxicity test  
 
Behavioural signs of toxicity observed in mice given 
1,000 mg extract/kg body weight and above include; paw 
licking, salivation, stretching and reduced activity. There 
was however no mortality at all the dose levels used. The 
median lethal dose LD50 was estimated to be 3807.89 





The ethanolic extract of P. thonningii exerted dose 
dependent chemosuppressive effect against P. berghei 
berghei malaria parasite. The extract caused a significant 
(p < 0.05) chemo suppression when compared to the 








Table 2. Suppressive effect of P. thonningii ethanolic leaf extracts and chloroquine against P. berghei 
berghei  infection in mice. 
 
Treatment Parasite count % Suppression 
Normal saline 5 ml/kg (control) 6.2 ± 1.16 - 
Extract 100 mg/kg 2.36 ± 1.20* 61.94 
Extract 200 mg/kg 1.34 ± 0.18* 78.39 
Extract 400 mg/kg 0.5 ± 0.28** 91.94 
CQ 5 mg/kg 0.074 ± 0.018** 98.81 
 
*Significantly different (p < 0.05) from the control. 




Table 3.  Curative effect of P. thonningii ethanolic leaf extracts and chloroquine against P. berghei berghei  
established infection in mice. 
 
Treatment Parasite count % suppression 
Normal saline 5 ml/kg (control) 18 ± 0.63 - 
Extract 100 mg/kg 9.5 ± 0.29* 47.22% 
Extract 200 mg/kg 8.5 ± 0.65* 52.78% 
Extract 400 mg/kg 7.0 ± 0.41* 61.11% 
CQ 5 mg/kg 4.25 ± 0.48** 76.39% 
 
*Significantly different (p < 0.05) from the control. 




suppression of 98.81%, which was higher than those of 





It was observed that the ethanol ic leaf extract of P. 
thonningii  produced daily, dose dependent reduction in 
parasitaemia levels in the extract treated groups, with a 
similar reduction in the chloroquine treated group 
(positive control). However, there was a daily increase in 
parasitaemia in the negative control group. The average 
percentage suppression of parasitaemia of the extract 
treated groups on day 7 were 47.22, 52.78 and 61.11% 
for the 100, 200 and 400 mg/kg/day of the extract 
respectively. While that of the chloroquine treated group 
was 76.39% (Table 3).  
 
 
Prophylactic effect  
 
The ethanolic leaf extracts of P. thorningii exerted 
significant (P < 0.05) dose dependent reduction in level of 
parasiteamia of 34.21, 44.74, 60.53% and 78. 90% at 
100 mg/kg, 200 mgkg, 400 mg/kg and the chloroquine 
treated groups, respectively (Table 4).   
DISCUSSION 
 
The rodent model of malaria has been employed in this 
study for prediction of efficacy of ant malaria effect of P. 
thoningii leaf extract. Several conventional anti malaria 
agents such as chloroquine, halofantrine, mefloquine and 
more recently artemisinin derivatives have been identified 
using rodent malaria model (David et al., 2004). P. 
berghei berghei are used in the prediction of treatment 
outcomes, hence it was an appropriate parasite for the 
study. Since this parasite is sensitive to chloroquine, this 
drug was used as the standard drug in this study. 
The choice of 4 weeks old mice for the study was done 
to avoid the effect of anaemia in the old mice and the 
effect of possible physiological changes associated with 
ageing may induce on the treatment outcome (Pierrot et 
al., 2003). The in vivo model was employed for this study 
because it takes into account possible prodrug effect and 
possible involvement of immune system in eradication of 
infection (Waako et al., 2005). The oral median lethal 
dose of 3807.89 mg/kg body weight obtained for the 
ethanolic leaf extract of P. thoningii is 19 times greater 
than the minimum effective dose of 200 mg/kg. Earlier 
reports have shown that if the median lethal dose of a test 
substance is three times more than the minimum effective 








Table 4. Prophylactic effect of P. thonningii ethanolic leaf extracts and chloroquine against P. berghei 
berghei (Repository test). 
 
Treatment Parasite count % Suppression 
Normal saline 5 ml/kg(control) 7.6 ± 0.68 - 
Extract 100 mg/kg 5.0 ± 0.48 34.21% 
Extract 200 mg/kg 4.2 ± 0.37* 44.74% 
Extract 400 mg/kg 3.0 ± 0.32* 60.53% 
CQ 5 mg/kg 1.6 ± 0.19** 78.90% 
 
*Significantly different (p < 0.05) from the control. 




further studies. It was also reported that oral adminis-
tration is about 100 times less toxic than the intra-
peritonial (Jutamaad et al., 1998). The extract is therefore 
safe and this could explain the safe use of the plant by 
the local people who have been using it in traditional 
management of malaria in Nigeria. The ethanolic extract 
is therefore a good candidate for further studies.  
The 4-day suppressive test is a standard test commonly 
used for antimalarial screening and the determination of 
percent inhibition of parasitaemia is the most reliable 
parameter. A mean group para sitaemia level of less than 
or equal to 90% of the mock-treated control animals usually 
indicate that the test material is active in standard 
screening studies (Peter and Anatoli., 1998). The results 
obtained from our study showed significant decrease in 
parasitaemia of P. berghei berghei infected mice treated 
with the ethanolic leaf extract of p. thorningii. This 
significant suppression of parasitaemia observed was 
dose dependent. The crude extract caused 91.94% sup-
pression in parasitaemia of P berghei infected mice while 
chloroquine a standard antimalaria drug exerted 98.81% 
suppression. When a standard antimalarial drug is used in 
mice infected with P. berghei, it suppresses parasitaemia 
to non-detectable levels (Kiseko et al., 2000), just like the 
effect of chloroquine in this study. The observed 
antimalaria activity is consistent with the traditional use of 
the plant as a herbal medication against the disease in 
Nigeria. The extract exerted significantly repository effect 
in mice treated with 200 and 400 mg/kg body weight 
(Table 2). This effect was however lower in group that 
received low dose. This effect may be due to short 
duration of action of the extract occasioned by rapid 
metabolism and so parasite clearance could not be total. 
It may also be explained by the fact that not all anti-
malarials are completely active against the P. berghei 
model (Dow et al., 1998). The extract demonstrated a 
significant pro-phylactic effect against P. berghei infected 
mice as demonstrated by the reduction in the level of 
parasitaemia dose dependently (Table 3). It is evident 
based on these findings that P. thorningii possess potent 
anti-plasmodial effect justifying its folkloric usage in the 
management of malaria. This effects may be attributed to 
the presence of alkaloids, terpenes and flavonoids that 
have been implicated in antiplasmodial activity (Phlipson 
and Wright, 1990; Christensen and Kharazmi, 2001). 
However, the active principle(s) are yet to be identified and 
there is need for the identification. In view of this fact, 
attempts are being made to carry out anti-plasmodial 
guided fractionation of the ethanolic extract to isolate the 
active compounds and also to test for the cytotoxicity of 
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